ALK-EML4 rearrangement is the consequence of a gene fusion in chromosome 2 between ALK gene and EML4 gene which leads to the activation of the tyrosine kinase domain of ALK protein that enhances tumor growth and proliferation [2]. This evidence concerns the gene ALK and neoplasm.